ArticleInternational journal of hematology2023

Lenalidomide treatment of Japanese patients with myelodysplastic syndromes with 5q deletion: a post-marketing surveillance study.

Shuji Uno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.